Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Detalles Bibliográficos
Autores principales: Yamasaki, Satoshi, Matsushima, Takumi, Minami, Mariko, Kadowaki, Masanori, Takase, Ken, Iwasaki, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779080/
https://www.ncbi.nlm.nih.gov/pubmed/33392703
http://dx.doi.org/10.1007/s00277-020-04388-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779080/
https://www.ncbi.nlm.nih.gov/pubmed/33392703
http://dx.doi.org/10.1007/s00277-020-04388-6

Ejemplares similares